Transcription of New response evaluation criteria in solid tumours: Revised ...
{{id}} {{{paragraph}}}
New response evaluation criteria in solid tumours: Revised RECIST guideline (version ) Eisenhauera,*, P. Therasseb, J. Bogaertsc, Schwartzd, D. Sargente, R. Fordf,J. Danceyg, S. Arbuckh, S. Gwytheri, M. Mooneyg, L. Rubinsteing, L. Shankarg, L. Doddg,R. Kaplanj, D. Lacombec, J. VerweijkaNational Cancer Institute of Canada Clinical Trials Group, 10 Stuart Street, Queen s University, Kingston, ON, CanadabGlaxoSmithKline Biologicals, Rixensart, BelgiumcEuropean Organisation for Research and Treatment of Cancer, Data Centre, Brussels, BelgiumdMemorial Sloan Kettering Cancer Center, New York, NY, USAeMayo Clinic, Rochester, MN, USAfRadPharm, Princeton, NJ, USAgDivision of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, U
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) ... ability to recommend adoption of these alternative assess-ment methods. ... later in this guideline. As detailed in paper in this special issue12, we believe that the use of these prom-ising newer approaches (which could eitheradd to orsubstitute for ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}